At the time of writing, Biomerica Inc [BMRA] stock is trading at $0.75, up 43.90%. An important factor to consider is whether the stock is rising or falling in short-term value. The BMRA shares have gain 59.83% over the last week, with a monthly amount glided 129.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biomerica Inc [NASDAQ: BMRA] stock has seen the most recent analyst activity on November 10, 2020, when Colliers Securities initiated its Buy rating and assigned the stock a price target of $13. Previously, B. Riley FBR Inc. started tracking the stock with Buy rating on January 04, 2018, and set its price target to $7.50.
For the past year, the stock price of Biomerica Inc fluctuated between $0.24 and $1.35. Biomerica Inc [NASDAQ: BMRA] shares were valued at $0.75 at the most recent close of the market.
Analyzing the BMRA fundamentals
According to Biomerica Inc [NASDAQ:BMRA], the company’s sales were 5.58M for trailing twelve months, which represents an 4.40% jump. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -1.06%, Pretax Profit Margin comes in at -1.0%, and Net Profit Margin reading is -1.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -0.9 and Total Capital is -1.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6010 points at the first support level, and at 0.4500 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8420, and for the 2nd resistance point, it is at 0.9320.
Ratios To Look Out For
It is important to note that Biomerica Inc [NASDAQ:BMRA] has a current ratio of 3.17. On the other hand, the Quick Ratio is 2.22, and the Cash Ratio is 1.26. Considering the valuation of this stock, the price to sales ratio is 2.47, the price to book ratio is 2.70.
